Purified Rabbit Anti-human/mouse PAG1 Antibody *PAb (409), monoclonal*
Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 (alternatively called Transmembrane adapter protein PAG, Transmembrane phosphoprotein Cbp or Csk-binding protein) is a transmembrane protein with a molecular weight of 47 kDa, found in the membrane raft, integral component of membrane and plasma membrane of cells. Sequencing of transmembrane adapter protein PAG has shown evidence that it contains 2 types of conserved structural units: extracellular and cytoplasmic domain. Transmembrane adapter protein PAG aids in T cell activation. It is the subject of intensive research stemming from the fact that it is involved with the T cell receptor signaling pathway. Transmembrane adapter protein PAG is thought to be essential to organismal processes, for example, intracellular signal transduction, adaptive immune response and signal transduction. It acts to negatively regulate T cell activation. Transmembrane adapter protein PAG binds with SH2 domain and S-palmitoyl cysteine.
Conjugation
We provide custom conjugation services for this antibody (eg. labeling of PAG1 antibody with HRP). A list of available labels can be found in the table below:
For additional information about custom conjugations, please consult our services page here.
AF | AF350, AF488, AF555, AF594, AF647, AF680, AF700, AF750 |
Proteins | HRP, Alkaline Phosphatase, Streptavidin |
Tandems | APC, APC/Cy7, APC/AF750, APC/iFluor™ 700, APC/iFluor™ 750, PE, PE/Cy5, PE/Cy7, PE/AF610, PE/AF700, PE/iFluor™ 594, PE/iFluor™ 647, PE/iFluor™ 700, PE/iFluor™ 750, PE/Texas Red®, PerCP, PerCP/Cy5.5 |
Small Molecules | Biotin |
Traditional Dyes | FITC (fluorescein), TRITC, PacBlue, PacOrange, Cy3, Cy5 |
iFluor | 350, 405, 430, 450, 488, 514, 532, 546, 555, 560, 568, 594, 610, 633, 647, 660, 670, 680, 700, 710, 750, 790, 800, 810, 820, 840, 860, A7 |
mFluor | UV375, UV460, Violet 450, Violet 500, Violet 510, Violet 540, Blue 570, Green 620, Red 700, Red 780 |
For additional information about custom conjugations, please consult our services page here.
Page updated on December 17, 2024